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Figure S6
. Difference (95% CI) for a two-fold increase in maternal SG-standardized urinary phthalate concentrations in relation to children's SRS-2 T-scores at 3-4 years, using Inverse probability censoring weights to adjust for potential selection bias. β represents the change in point score for a two-fold increase in urinary phthalate concentration. Significant effectmodification by sex at p<0.1 is indicated by red asterisks. Figure S7 . Difference (95% CI) for a two-fold increase in maternal SG-standardized urinary phthalate concentrations in relation to children's SRS-2 T-scores at 3-4 years, stratified by folic acid supplementation during pregnancy categorized into three categories (<400 µg/day; 400-999 µg/day; ≥1000 µg/day). Table S3 : Associations between maternal SG-standardized urinary phthalate concentrations (for a twofold increase) and children's SRS-2 T-scores at 3-4 years, stratified by folic acid (FA) supplementation during pregnancy.
SRS subscale Phthalate
Inadequate folate status (<400µg/day)
Social Communication MBP 1.0 (0.1, 1.9) 0.5 (0.0, 0.9) 0.27 MBzP 0.6 (-0.4, 1.6) Figure 3 . p-phthalate X FA: p-value for the interaction between phthalates concentrations and FA supplementation (<400µg/day / ≥400µg/day). Table S4 : Associations between maternal SG-standardized urinary phthalate concentrations and children's SRS-2 T-scores at 3-4 years, with adjustment for additional predictors of SRS scores. β represents the change in point score for a two-fold increase in urinary phthalate concentration.
Restricted Interests / Repetitive Behavior
MBP 1.0 (0.0, 2.1) 0.4 (-0.1, 0.9) 0.19 MBzP 1.1 (0.0, 2.3) 0.1 (-0.3, 0.6) 0.08 MEP -0.1 (-1.0, 0.8) -0.1 (-0.4,
SRS subscale Phthalate
All All models were adjusted for study city, child sex, household income, maternal education, maternal age, parity, marital status, race/ethnicity, folic acid supplementation, year of enrollment, smoking during pregnancy, alcohol during pregnancy, 1 st trimester blood lead concentrations, admission at a neonatal intensive care unit, Home Observation and Measurement of the Environment (HOME) scores, and exclusive breastfeeding duration. p-phthalate X Sex: p-value for the interaction term between phthalates concentrations and Sex in the models. All models were adjusted for study city, household income, maternal education, maternal age, parity, marital status, race/ethnicity, folic acid supplementation, and year of enrollment. p-difference corresponds to the comparison of d/SE d to the standard normal distribution, where d is the difference between the two estimates, and is the standard error of the difference. All models were adjusted for study city, household income, maternal education, maternal age, parity, marital status, race/ethnicity, folic acid supplementation, specific gravity, and year of enrollment. pphthalate X Sex: p-value for the interaction term between phthalates concentrations and Sex in the models.
Figure S1: Flow chart of the study participants. Figure S2 . Directed acyclic graph representing the associations between phthalates, autistic traits, and potential confounders Figure S3 . Minimum set of covariates sufficient to identify the potential effect of phthalates on autistic traits. Red squares indicate the variables to adjust for. Figure S4 : Exposure-response relationship and 95% confidence intervals for the associations between between maternal SG-standardized urinary MCPP concentrations and child SRS T-scores at 3-4 years.
DF: degrees of freedom for the smooth term; p-values for significance (p) were derived with Wald tests using the Bayesian covariance matrix for the coefficients and departure from linearity (p-departure) were derived by comparing the models with urinary phthalate concentrations introduced as a spline function and as a linear term. Figure S5 : Exposure-response relationship between maternal SG-standardized urinary phthalates concentrations and child total SRS T-scores at 3-4 years, by child sex Figure S6 : Difference (95% CI) for a two-fold increase in maternal SG-standardized urinary phthalate concentrations in relation to children's SRS-2 T-scores at 3-4 years, using Inverse probability censoring weights to adjust for potential selection bias. β represents the change in point score for a two-fold increase in urinary phthalate concentration. Significant effect-modification by sex at p<0.1 is indicated by red asterisks. Figure S7 : Difference (95% CI) for a two-fold increase in maternal SG-standardized urinary phthalate concentrations in relation to children's SRS-2 T-scores at 3-4 years, stratified by folic acid supplementation during pregnancy categorized into three categories (<400 µg/day; 400-999 µg/day; ≥1000 µg/day).
